New study tests pain pump drug for chemo nerve damage
NCT ID NCT07499882
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether ziconotide, a drug given through a pump in the spine, can reduce nerve pain caused by chemotherapy. Researchers will track pain levels and daily function in 24 adults over 24 months. The goal is to see if this already-approved pain treatment can help people with this common, long-lasting side effect of cancer treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Christian Hospital
St Louis, Missouri, 63136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Acupuncture vs. sham needles: a test for chemo nerve damage
- Could a simple vibrating pad ease chemo nerve damage?
- Video analysis could personalize rehab for chemo nerve damage
- Brain training and nerve stretching could ease chemo nerve damage
- Acupuncture and exercise join forces against chemotherapy nerve pain
- New drug candidate AH-008 takes first step toward easing chemotherapy nerve pain